Final safety and efficacy of erlotinib in the phase 4 POLARSTAR surveillance study of 10 708 Japanese patients with non‐small‐cell lung cancer
A Gemma, S Kudoh, M Ando, Y Ohe… - Cancer …, 2014 - Wiley Online Library
… Japanese patients with NSCLC treated with erlotinib,9 undertaken as a post-approval
commitment in Japan … safety and efficacy of erlotinib treatment in Japanese patients with NSCLC. …
commitment in Japan … safety and efficacy of erlotinib treatment in Japanese patients with NSCLC. …
Phase II study of adjuvant vinorelbine and cisplatin in Japanese patients with completely resected stage II and III non-small cell lung cancer
M Sonobe, K Okubo, S Teramukai… - Cancer chemotherapy …, 2014 - Springer
… Caucasian patient population to the corresponding Japanese patient … Japanese patient
population before the application of the regimen in clinical practice to a wide range of patients …
population before the application of the regimen in clinical practice to a wide range of patients …
Real-world practice patterns for patients with advanced non-small cell lung cancer: multicenter retrospective cohort study in Japan
H Isobe, K Mori, K Minato, H Katsura… - Lung Cancer: Targets …, 2017 - Taylor & Francis
… Recommended therapies for advanced/metastatic non-small cell lung cancer (NSCLC) have
… health care resource use for advanced NSCLC at 5 sites in Japan. Patients and methods …
… health care resource use for advanced NSCLC at 5 sites in Japan. Patients and methods …
Cross-cultural validation of the Japanese version of the lung cancer subscale on the functional assessment of cancer therapy-lung
E Saitoh, Y Yokomizo, CH Chang… - Journal of Nippon …, 2007 - jstage.jst.go.jp
… In conclusion, the Japanese version of the LCS can be used to evaluate multiple symptoms
in Japanese patients with lung cancer as can the original English LCS. In Japan, the LCS …
in Japanese patients with lung cancer as can the original English LCS. In Japan, the LCS …
… -generation regimens with concurrent thoracic radiotherapy in patients with unresectable stage III non–small-cell lung cancer: West Japan Thoracic Oncology Group …
N Yamamoto, K Nakagawa, Y Nishimura… - Journal of clinical …, 2010 - ascopubs.org
… Lung cancer remains the leading cause of cancer-related … -cell lung cancer (NSCLC)
accounts for 80% of all lung cancer … of patients with NSCLC present with locally advanced lung …
accounts for 80% of all lung cancer … of patients with NSCLC present with locally advanced lung …
Phase I study of ipilimumab in phased combination with paclitaxel and carboplatin in Japanese patients with non-small-cell lung cancer
H Horinouchi, N Yamamoto, Y Fujiwara, I Sekine… - Investigational new …, 2015 - Springer
… In this phase I study in Japanese patients with advanced NSCLC using the definition defined
in … This dosage of ipilimumab is being studied in two on-going phase III lung cancer studies: …
in … This dosage of ipilimumab is being studied in two on-going phase III lung cancer studies: …
[HTML][HTML] Recent trends in the incidence of latent tuberculosis infection in Japanese patients with lung cancer: A small retrospective study
A Tamura, T Fukami, A Hebisawa… - Journal of Infection and …, 2020 - Elsevier
… of patients with active tuberculosis comorbid with lung cancer will greatly decrease in the future
in Japan. … improvements in lung cancer prognosis due to advances in cancer medication, …
in Japan. … improvements in lung cancer prognosis due to advances in cancer medication, …
Osimertinib in Japanese patients with EGFR T790M mutation‐positive advanced non‐small‐cell lung cancer: AURA3 trial
H Akamatsu, N Katakami, I Okamoto, T Kato… - Cancer …, 2018 - Wiley Online Library
… This subanalysis evaluated the safety and efficacy of osimertinib specifically in 63 Japanese
patients enrolled in AURA 3. The primary end‐point was progression‐free survival ( PFS ) …
patients enrolled in AURA 3. The primary end‐point was progression‐free survival ( PFS ) …
EGFR Mutation Status in Japanese Lung Cancer Patients: Genotyping Analysis Using LightCycler
H Sasaki, K Endo, A Konishi, M Takada… - Clinical cancer …, 2005 - AACR
… were found in ∼25% of Japanese lung cancer patients. These EGFR mutations are reported
… status in Japanese lung cancer patients, including 102 surgically treated lung cancer cases …
… status in Japanese lung cancer patients, including 102 surgically treated lung cancer cases …
… survey of cancer cachexia in advanced non-small cell lung cancer patients—Japan nutrition and QOL survey in patients with advanced non-small cell lung cancer …
K Takayama, S Atagi, F Imamura, H Tanaka… - … Care in Cancer, 2016 - Springer
… patients with advanced non-small cell lung cancer (NSCLC). This study was conducted as
the Japan Nutrition and QOL survey in patients … in further understanding cancer cachexia and …
the Japan Nutrition and QOL survey in patients … in further understanding cancer cachexia and …